Patent Assignment
Reel/Frame 063697/0461
Patent Security Agreement
Recorded: 2023-05-18
Pages: 16
Assignors
REATA PHARMACEUTICALS HOLDINGS, LLC
Executed: 2023-05-12
REATA PHARMACEUTICALS GLOBAL, INC.
Executed: 2023-05-12
REATA PHARMACEUTICALS, INC.
Executed: 2023-05-12
Assignee
BIOPHARMA CREDIT PLC
C/O BEAUFORT HOUSE, 51 NEW NORTH ROAD, EXETER EX4 4EP, UNITED KINGDOM
Covered Properties
(88)
Co-Crystal Forms of a Novobiocin Analog and Proline
Application:
18/168,495 →
Publication:
US 2024/0043465
Antioxidant Inflammation Modulators: Oleanolic Acid Derivatives with Amino and Other Modifications at C-17
2,2-Difluoropropionamide Derivatives of Bardoxolone Methyl, Polymorphic Forms and Methods of Use Thereof
Pyrazolyl and Pyrimidinyl Tricyclic Enones as Antioxidant Inflammation Modulators
Methods of Treating and Preventing Endothelial Dysfunction Using Bardoxolone Methyl or Analogs Thereof
Application:
16/157,225 →
Publication:
US 2019/0091194
C-Terminal HSP90 Inhibitors
Biphenyl Amides with Modified Ether Groups as HSP90 Inhibitors and HSP70 Inducers
C4-Modified Oleanolic Acid Derivatives for Inhibition of Il-17 and Other Uses
Biaryl Amides with Modified Sugar Groups for Treatment of Diseases Associated with Heat Shock Protein Pathway
Pyrimidine Tricyclic Enone Derivatives for Inhibition of Ror-Gamma and Other Uses
Pyrazole and Imidazole Compounds for Inhibition of Il-17 and Rorgamma
Cysteine-Dependent Inverse Agonists of Nuclear Receptors Ror-Gamma/Ror-Gamma-T and Methods of Treating Diseases or Disorders Therewith
C17 Polar-Substituted Heteroaromatic Synthetic Triterpenoids and Methods of Use Thereof
Synthetic Triterpenoids with Nitrogen-Based Substituents at C-17 and Methods of Use Thereof
Application:
17/757,701 →
Publication:
US 2023/0111914
2,2-Difluoropropionamide Derivatives of Bardoxolone Methyl, Polymorphic Forms and Methods of Use Thereof
Methods of Treating Covid-19 Using Bardoxolone Methyl or Analogs Thereof
Application:
17/998,291 →
Publication:
US 2023/0255982
Synthetic Triterpenoids and Methods of Use in the Treatment of Disease
Application:
15/675,862 →
Publication:
US 2018/0161311
Methods of Treating Obesity Using Antioxidant Inflammation Modulators
Novel Forms of Cddo Methyl Ester
Novel Forms of Cddo Methyl Ester
Novel Forms of Cddo Methyl Ester
Delayed Release, Oral Dosage Compositions That Contain Amorphous Cddo-Me
Delayed Release, Oral Dosage Compositions That Contain Amorphous Cddo-Me
Co-Crystal Forms of a Novobiocin Analog and Proline
Co-Crystal Forms of a Novobiocin Analog and Proline
A-Ring Epoxidized Triterpenoid-Based Anti-Inflammation Modulators and Methods of Use Thereof
Dehydroandrosterone Analogs Including an Anti-Inflammatory Pharmacore and Methods of Use
Natural Product Analogs Including an Anti-Inflammatory Cyanoenone Pharmacore and Methods of Use
Natural Product Analogs Including an Anti-Inflammatory Cyanoenone Pharmacore and Methods of Use
Antioxidant Inflammation Modulators: Oleanolic Acid Derivatives with Saturation in the C-Ring
Patent:
45,325 →
Application:
14/080,414 →
Antioxidant Inflammation Modulators: Oleanolic Acid Derivatives with Saturation in the C-Ring
Antioxidant Inflammation Modulators: Oleanolic Acid Derivatives with Saturation in the C-Ring
Antioxidant Inflammation Modulators: Oleanolic Acid Derivatives with Saturation in the C-Ring
Patent:
45,288 →
Application:
14/080,267 →
Antioxidant Inflammation Modulators: Oleanolic Acid Derivatives with Amino and Other Modifications at C-17
Antioxidant Inflammation Modulators: Oleanolic Acid Derivatives with Amino and Other Modifications at C-17
Antioxidant Inflammation Modulators: Oleanolic Acid Derivatives with Amino and Other Modifications at C-17
Antioxidant Inflammation Modulators: Oleanolic Acid Derivatives with Amino and Other Modifications at C-17
Antioxidant Inflammation Modulators: Oleanolic Acid Derivatives with Amino and Other Modifications at C-17
Antioxidant Inflammation Modulators: Oleanolic Acid Derivatives with Amino and Other Modifications at C-17
Antioxidant Inflammation Modulators: Oleanolic Acid Derivatives with Amino and Other Modifications at C-17
Antioxidant Inflammation Modulators: Novel Derivatives of Oleanolic Acid
Antioxidant Inflammation Modulators: C-17 Homologated Oleanolic Acid Derivatives
Antioxidant Inflammation Modulators: C-17 Homologated Oleanolic Acid Derivatives
Antioxidant Inflammation Modulators: C-17 Homologated Oleanolic Acid Derivatives
Methods of Treating Obesity Using Antioxidant Inflammation Modulators
Pyrazolyl and Pyrimidinyl Tricyclic Enones as Antioxidant Inflammation Modulators
Pyrazolyl and Pyrimidinyl Tricyclic Enones as Antioxidant Inflammation Modulators
Pyrazolyl and Pyrimidinyl Tricyclic Enones as Antioxidant Inflammation Modulators
Pyrazolyl and Pyrimidinyl Tricyclic Enones as Antioxidant Inflammation Modulators
C4 Monomethyl Triterpenoid Derivatives and Methods of Use Thereof
2,2-Difluoropropionamide Derivatives of Bardoxolone Methyl, Polymorphic Forms and Methods of Use Thereof
2,2-Difluoropropionamide Derivatives of Bardoxolone Methyl, Polymorphic Forms and Methods of Use Thereof
2,2-Difluoropropionamide Derivatives of Bardoxolone Methyl, Polymorphic Forms and Methods of Use Thereof
C17-Alkanediyl and Alkenediyl Derivatives of Oleanolic Acid and Methods of Use Thereof
C17-Alkanediyl and Alkenediyl Derivatives of Oleanolic Acid and Methods of Use Thereof
C17-Heteroaryl Derivatives of Oleanolic Acid and Methods of Use Thereof
C17-Heteroaryl Derivatives of Oleanolic Acid and Methods of Use Thereof
C17-Heteroaryl Derivatives of Oleanolic Acid and Methods of Use Thereof
C17-Heteroaryl Derivatives of Oleanolic Acid and Methods of Use Thereof
C17-Heteroaryl Derivatives of Oleanolic Acid and Methods of Use Thereof
C13-Hydroxy Derivatives of Oleanolic Acid and Methods of Use Thereof
Imidazolyl Tricyclic Enones as Antioxidant Inflammation Modulators
C-Terminal HSP90 Inhibitors
C-Terminal HSP90 Inhibitors
C-Terminal HSP90 Inhibitors
C-Terminal HSP90 Inhibitors
C-Terminal HSP90 Inhibitors
Dynamic Inhibitors of Heat Shock Protein 90
Coumarin Based HSP90 Inhibitors with Urea and Ether Substituents
Coumarin Based HSP90 Inhibitors with Urea and Ether Substituents
Biphenylamide Derivative HSP90 Inhibitors
Triazole Modified Coumarin and Biphenyl Amide-Based HSP90 Inhibitors
Biphenyl Amides with Modified Ether Groups as HSP90 Inhibitors and HSP70 Inducers
Biphenyl Amides with Modified Ether Groups as HSP90 Inhibitors and HSP70 Inducers
C4-Modified Oleanolic Acid Derivatives for Inhibition of Il-17 and Other Uses
Pyrimidine Tricyclic Enone Derivatives for Inhibition of Ror-Gamma and Other Uses
Methods of Treating Alport Syndrome Using Bardoxolone Methyl or Analogs Thereof
Methods of Treating Alport Syndrome Using Bardoxolone Methyl or Analogs Thereof
Aryl and Arylalkyl Substituted Pyrazolyl and Pyrimidinyl Tricyclic Enones as Antioxidant Inflammation Modulators
2,2-Difluoropropionamide Derivatives of Bardoxolone Methyl, Polymorphic Forms and Methods of Use Thereof
2,2-Difluoropropionamide Derivatives of Bardoxolone Methyl, Polymorphic Forms and Methods of Use Thereof
Cddo-Compounds and Combination Therapies Thereof
Inhibitors and Methods of Use Thereof
Synthetic Triterpenoids and Methods of Use in the Treatment of Disease
Synthetic Triterpenoids and Methods of Use in the Treatment of Disease
Synthetic Triterpenoids and Methods of Use in the Treatment of Disease
Methods of Administering Synthetic Triterpenoids
PCT:
PCT/US2021/072851 ↗
Synthetic Ursolic Acid Derivatives and Methods of Use Thereof
PCT:
PCT/US2022/012831 ↗
Related Assignments
(25)
Other recorded transfers of the patents in this record — the chain of ownership.
Assignment of Assignor's Interest
Oct 28, 2008
From: WALLING, JOHN; PARENT, STEPHAN D.; JONAITIS, DAVID T.; KRAL, ROBERT M., JR.
To: REATA PHARMACEUTICALS INC.
Reel/Frame 021750/0176 →
Assignment of Assignor's Interest
Aug 14, 2017
From: KRAL, ROBERT M.; MEYER, COLIN J.
To: REATA PHARMACEUTICALS, INC.
Reel/Frame 043278/0640 →
Assignment of Assignor's Interest
Aug 14, 2017
From: SPORN, MICHAEL B.; LIBY, KAREN T.; GRIBBLE, GORDON W.; HONDA, TADASHI
To: TRUSTEES OF DARTMOUTH COLLEGE
Reel/Frame 043539/0424 →
Security Interest
Jun 14, 2018
From: REATA PHARMACEUTICALS, INC.
To: OXFORD FINANCE LLC, AS COLLATERAL AGENT
Reel/Frame 046357/0605 →
Assignment of Assignor's Interest
Sep 26, 2018
From: MEYER, COLIN J.; HUFF, J. WARREN
To: REATA PHARMACEUTICALS, INC.
Reel/Frame 046974/0731 →
Assignment of Assignor's Interest
Oct 11, 2018
From: CHIN, MELANIE PEI-HENG; MEYER, COLIN J.
To: REATA PHARMACEUTICALS, INC.
Reel/Frame 047131/0022 →
Security Interest
Oct 9, 2019
From: REATA PHARMACEUTICALS, INC.
To: OXFORD FINANCE LLC, AS COLLATERAL AGENT
Reel/Frame 050670/0902 →
Release of Security Interest
Jun 24, 2020
From: OXFORD FINANCE LLC, AS COLLATERAL AGENT
To: REATA PHARMACEUTICALS, INC.
Reel/Frame 053034/0018 →
Assignment of Assignor's Interest
Aug 5, 2020
From: JIANG, XIN; BENDER, CHRISTOPHER F.; VISNICK, MELEAN; DO, HA
To: REATA PHARMACEUTICALS, INC.
Reel/Frame 053408/0192 →
Assignment of Assignor's Interest
Dec 16, 2020
From: VISNICK, MELEAN; JIANG, XIN
To: REATA PHARMACEUTICALS, INC.
Reel/Frame 054666/0617 →
Assignment of Assignor's Interest
Jan 20, 2021
From: BOLTON, GARY; CAPRATHE, BRADLEY; LEE, CHITASE
To: AAPHARMASYN LLC
Reel/Frame 054965/0334 →
Assignment of Assignor's Interest
Jan 20, 2021
From: JIANG, XIN; VISNICK, MELEAN; BENDER, CHRISTOPHER F.
To: REATA PHARMACEUTICALS, INC.
Reel/Frame 054965/0600 →
Assignment of Assignor's Interest
Jan 20, 2021
From: AAPHARMASYN LLC
To: REATA PHARMACEUTICALS, INC.
Reel/Frame 054965/0448 →
Assignment of Assignor's Interest
May 10, 2021
From: JIANG, XIN; VISNICK, MELEAN; BENDER, CHRISTOPHER F.; HOTEMA, MARTHA R.
To: REATA PHARMACEUTICALS, INC.
Reel/Frame 056188/0413 →
Assignment of Assignor's Interest
May 10, 2021
From: BOLTON, GARY; LEE, CHITASE; CAPRATHE, BRADLEY; KORNBERG, BRIAN
To: AAPHARMASYN LLC
Reel/Frame 056188/0077 →
Assignment of Assignor's Interest
May 10, 2021
From: AAPHARMASYN LLC
To: REATA PHARMACEUTICALS, INC.
Reel/Frame 056188/0224 →
Assignment of Assignor's Interest
Jun 25, 2021
From: ANDERSON, ERIC; LIU, XIAOFENG
To: REATA PHARMACEUTICALS, INC.
Reel/Frame 056669/0338 →
Assignment of Assignor's Interest
Jun 25, 2021
From: DECKER, ANDREA
To: SOLVIAS AG
Reel/Frame 056669/0175 →
Assignment of Assignor's Interest
Jun 25, 2021
From: SOLVIAS AG
To: REATA PHARMACEUTICALS, INC.
Reel/Frame 056669/0249 →
Assignment of Assignor's Interest
Jul 9, 2021
From: ANDERSON, ERIC; JIANG, XIN; VISNICK, MELEAN
To: REATA PHARMACEUTICALS, INC.
Reel/Frame 056800/0638 →
Assignment of Assignor's Interest
Aug 6, 2021
From: SHEIKH, AHMAD Y.; MATTEI, ALESSANDRA; WANG, XIU C.
To: ABBVIE INC.
Reel/Frame 057102/0759 →
Assignment of Assignor's Interest
Dec 3, 2021
From: REATA PHARMACEUTICALS, INC.
To: REATA PHARMACEUTICALS HOLDINGS, LLC
Reel/Frame 058301/0262 →
Assignment of Assignor's Interest
Dec 7, 2021
From: ANDERSON, ERIC; JIANG, XIN; VISNICK, MELEAN
To: REATA PHARMACEUTICALS, INC.
Reel/Frame 058315/0551 →
Assignment of Assignor's Interest
Dec 7, 2021
From: AAPHARMASYN LLC
To: REATA PHARMACEUTICALS, INC.
Reel/Frame 058315/0819 →
Assignment of Assignor's Interest
Dec 7, 2021
From: BOLTON, GARY L.; CAPRATHE, BRADLEY; LEE, CHITASE; ROARK, WILLIAM H.
To: AAPHARMASYN L.L.C
Reel/Frame 058315/0650 →